Dr. Taylor M. Ortiz
Claim this profileFranciscan Health Indianapolis
Studies Cancer
Studies Breast Cancer
7 reported clinical trials
19 drugs studied
Area of expertise
1Cancer
HER2 positive
Stage IV
ER positive
2Breast Cancer
Stage IV
HER2 positive
ER positive
Affiliated Hospitals
Clinical Trials Taylor M. Ortiz is currently running
Epoetin Alfa vs Luspatercept
for Myelodysplastic Syndrome
This trial is testing two treatments, Luspatercept and epoetin alfa, to see which is better for treating anemia in adults with certain types of myelodysplastic syndromes (MDS). The participants have not used similar treatments before and do not need regular blood transfusions. Luspatercept helps red blood cells mature, while epoetin alfa increases their production.
Recruiting2 awards Phase 3
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
More about Taylor M. Ortiz
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Taylor M. Ortiz has experience with
- Epoetin Alfa
- Luspatercept
- Abemaciclib
- Fulvestrant
- Placebo
- Trastuzumab Emtansine
Breakdown of trials Taylor M. Ortiz has run
Cancer
Breast Cancer
Tumors
Serous Cystadenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Taylor M. Ortiz specialize in?
Taylor M. Ortiz focuses on Cancer and Breast Cancer. In particular, much of their work with Cancer has involved HER2 positive patients, or patients who are Stage IV.
Is Taylor M. Ortiz currently recruiting for clinical trials?
Yes, Taylor M. Ortiz is currently recruiting for 4 clinical trials in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Taylor M. Ortiz has studied deeply?
Yes, Taylor M. Ortiz has studied treatments such as Epoetin Alfa, Luspatercept, Abemaciclib.
What is the best way to schedule an appointment with Taylor M. Ortiz?
Apply for one of the trials that Taylor M. Ortiz is conducting.
What is the office address of Taylor M. Ortiz?
The office of Taylor M. Ortiz is located at: Franciscan Health Indianapolis, Indianapolis, Indiana 46237 United States. This is the address for their practice at the Franciscan Health Indianapolis.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.